These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 8356803

  • 1. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ, McKeating JA, Schutten M, Reitz MS, Robert-Guroff M.
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [Abstract] [Full Text] [Related]

  • 2. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C.
    Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP, Geyer SJ, Hanson CV, Hendry RM, Milman G.
    AIDS; 1994 Feb 17; 8(2):169-81. PubMed ID: 7519019
    [Abstract] [Full Text] [Related]

  • 4. Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.
    Thali M, Charles M, Furman C, Cavacini L, Posner M, Robinson J, Sodroski J.
    J Virol; 1994 Feb 17; 68(2):674-80. PubMed ID: 7507184
    [Abstract] [Full Text] [Related]

  • 5. Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.
    McKeating JA, Zhang YJ, Arnold C, Frederiksson R, Fenyö EM, Balfe P.
    Virology; 1996 Jun 15; 220(2):450-60. PubMed ID: 8661395
    [Abstract] [Full Text] [Related]

  • 6. Antibody neutralization and escape by HIV-1.
    Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM.
    Nature; 2003 Mar 20; 422(6929):307-12. PubMed ID: 12646921
    [Abstract] [Full Text] [Related]

  • 7. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 8. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J, Yoshimura K, Honda A, Koito A, Murakami T, Matsushita S.
    J Virol; 2007 Apr 10; 81(8):3757-68. PubMed ID: 17251298
    [Abstract] [Full Text] [Related]

  • 9. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site.
    Chamat S, Nara P, Berquist L, Whalley A, Morrow WJ, Köhler H, Kang CY.
    J Immunol; 1992 Jul 15; 149(2):649-54. PubMed ID: 1378074
    [Abstract] [Full Text] [Related]

  • 10. Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization.
    Zhang YJ, Fredriksson R, McKeating JA, Fenyö EM.
    Virology; 1997 Nov 24; 238(2):254-64. PubMed ID: 9400598
    [Abstract] [Full Text] [Related]

  • 11. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL, Drummer HE, Wilson KA, Poumbourios P.
    J Virol; 2001 Jul 24; 75(14):6635-44. PubMed ID: 11413331
    [Abstract] [Full Text] [Related]

  • 12. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
    Song B, Cayabyab M, Phan N, Wang L, Axthelm MK, Letvin NL, Sodroski JG.
    Virology; 2004 Apr 25; 322(1):168-81. PubMed ID: 15063126
    [Abstract] [Full Text] [Related]

  • 13. Two new human monoclonal antibodies against HIV type 1 glycoprotein 120: characterization and neutralizing activities against HIV type 1 strains.
    Février M, Boudet F, Deslandres A, Theze J.
    AIDS Res Hum Retroviruses; 1995 Apr 25; 11(4):491-500. PubMed ID: 7543271
    [Abstract] [Full Text] [Related]

  • 14. Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F.
    Revilla A, Delgado E, Christian EC, Dalrymple J, Vega Y, Carrera C, González-Galeano M, Ocampo A, de Castro RO, Lezaún MJ, Rodríguez R, Mariño A, Ordóñez P, Cilla G, Cisterna R, Santamaría JM, Prieto S, Rakhmanova A, Vinogradova A, Ríos M, Pérez-Álvarez L, Nájera R, Montefiori DC, Seaman MS, Thomson MM.
    AIDS Res Hum Retroviruses; 2011 Aug 25; 27(8):889-901. PubMed ID: 21226626
    [Abstract] [Full Text] [Related]

  • 15. The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies.
    Peachman KK, Wieczorek L, Polonis VR, Alving CR, Rao M.
    Virology; 2010 Dec 20; 408(2):213-23. PubMed ID: 20961591
    [Abstract] [Full Text] [Related]

  • 16. An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization.
    Back NK, Smit L, De Jong JJ, Keulen W, Schutten M, Goudsmit J, Tersmette M.
    Virology; 1994 Mar 20; 199(2):431-8. PubMed ID: 8122371
    [Abstract] [Full Text] [Related]

  • 17. Epitopes of HIV-1 glycoproteins recognized by the human immune system.
    Laal S, Zolla-Pazner S.
    Chem Immunol; 1993 Mar 20; 56():91-111. PubMed ID: 7680869
    [No Abstract] [Full Text] [Related]

  • 18. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
    Boudet F, Theze J, Zouali M.
    Virology; 1994 Apr 20; 200(1):176-88. PubMed ID: 7510435
    [Abstract] [Full Text] [Related]

  • 19. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY, Hariharan K, Posner MR, Nara P.
    J Immunol; 1993 Jul 01; 151(1):449-57. PubMed ID: 7686944
    [Abstract] [Full Text] [Related]

  • 20. N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.
    McCaffrey RA, Saunders C, Hensel M, Stamatatos L.
    J Virol; 2004 Apr 01; 78(7):3279-95. PubMed ID: 15016849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.